July 10, 2018 // by Lene Andersen
Dawn Richards presenting the CAPA methotraxate tool at the Annual European Congress of Rheumatology “We all have a story about methotrexate,” said Dawn Richards, Vice President of the Canadian Arthritis Patient Alliance (CAPA) Steering Committee. This medication has been around for a long time and is considered the gold standard for treatment of inflammatory arthritis….
Category: Juvenile Arthritis, People Doing Good Things, RA
Tag: coping, EULAR, medications, methotrexate, side effects
How we use cookies
We use some essential cookies to make this website work. We'd like to set additional cookies to provide social media features, to analyse our traffic, and to remember your settings and repeat visits. By selecting “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |